Lilly Health™ аналитика приложений для 2 декабря

Lilly Health™: Your journey, your way Whether you’re on Zepbound® (tirzepatide) or Mounjaro® (tirzepatide), Lilly Health™ offers personalized information, education, and insights to help you feel supported throughout your treatment journey, at no cost. Please see Indication and Safety Summary with Warnings for Mounjaro at mounjaro.lilly.com/risk Please see Indications and Safety Summary with Warnings for Zepbound at zepbound.lilly.com/risk When you download and use the Lilly Health™ mobile app, features will be customized based on your treatment and condition and may include: LOGBOOK: Track medicines, activity, and more—all in one place. PERSONALIZED SUPPORT: Lilly Health™ offers personalized information, education and insights to help you feel supported on your treatment journey—plus timely notifications to help keep your momentum going. CUSTOMIZE ALERTS: Set up dosing reminders to help stay on track with your medicine. VISUALIZE TRENDS: Review patterns, trends, and progress using charts and custom time ranges to share with your Health Care Provider. MEDICINE SUPPORT: Access savings information, keep track of your dose, and make updates if you and your doctor decide to make any changes. CONNECT DEVICES: You can choose to sync smart devices and apps for your convenience. LEARN & EXPLORE: Discover helpful articles, healthy recipes, and guided movement videos in our content library. Note: This app is intended for the exclusive use of U.S. residents 18 years of age and older. Lilly Health™ is not intended to provide treatment decisions or replace the care and advice of a licensed Health Care Provider (HCP). All medical analysis and treatment plans should be performed by a licensed HCP. Still have questions? Call 1-800-LillyRx (1-800-545-5979) for additional support (available Monday to Friday 9 am - 5 pm EST). ​​​Zepbound® and Mounjaro®​ are registered trademarks and Lilly Health™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.